Published in J Gastroenterol on March 01, 2010
Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe (2010) 4.54
Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol (2010) 2.22
IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol (2012) 2.03
LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol (2010) 1.85
Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS One (2011) 1.58
Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis (2010) 1.44
Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol (2014) 1.25
Immunopathogenesis of inflammatory bowel disease. Self Nonself (2011) 1.24
Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease. Gastroenterology (2011) 1.24
Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch Biochem Biophys (2011) 1.09
Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger. Immunol Cell Biol (2011) 1.07
T cell tolerance and immunity to commensal bacteria. Curr Opin Immunol (2012) 1.06
The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study. PLoS One (2013) 1.03
A comprehensive evaluation of colonic mucosal isolates of Sutterella wadsworthensis from inflammatory bowel disease. PLoS One (2011) 0.96
Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease. World J Gastroenterol (2015) 0.94
Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. Int J Med Microbiol (2014) 0.93
Pathogenesis of Crohn's disease: Bug or no bug. World J Gastrointest Pathophysiol (2015) 0.84
The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes Infect (2014) 0.82
Innate immune sensors and gastrointestinal bacterial infections. Clin Dev Immunol (2011) 0.81
Targeting aldose reductase for the treatment of cancer. Curr Cancer Drug Targets (2011) 0.81
RNA-seq analysis reveals significant transcriptome changes in turbot (Scophthalmus maximus) suffering severe enteromyxosis. BMC Genomics (2014) 0.80
Microbiome, Metabolome and Inflammatory Bowel Disease. Microorganisms (2016) 0.78
Spontaneous remission of Crohn's disease following a febrile infection: case report and literature review. BMC Gastroenterol (2011) 0.77
Efficacy of oral fecal bacteriotherapy in rhesus macaques (Macaca mulatta) with chronic diarrhea. Comp Med (2013) 0.77
Cultured enterocytes internalise bacteria across their basolateral surface for, pathogen-inhibitable, trafficking to the apical compartment. Sci Rep (2015) 0.75
Sex Differences in the Effect of Resveratrol on DSS-Induced Colitis in Mice. Gastroenterol Res Pract (2017) 0.75
Role of Salmonella enterica exposure in Chilean Crohn's disease patients. World J Gastroenterol (2013) 0.75
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49
Unravelling the pathogenesis of inflammatory bowel disease. Nature (2007) 18.52
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med (2001) 18.25
Hay fever, hygiene, and household size. BMJ (1989) 15.94
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet (2006) 15.14
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology (2004) 14.78
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet (2002) 14.14
The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 13.87
A microbial symbiosis factor prevents intestinal inflammatory disease. Nature (2008) 13.15
Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell (2004) 12.71
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest (2006) 11.89
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature (2008) 11.39
Increased expression of interleukin 17 in inflammatory bowel disease. Gut (2003) 9.16
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86
Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol (2007) 7.43
The gut flora as a forgotten organ. EMBO Rep (2006) 7.42
The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett (2002) 7.29
A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol (2005) 6.77
Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J Infect Dis (1985) 6.32
Revision of Campylobacter, Helicobacter, and Wolinella taxonomy: emendation of generic descriptions and proposal of Arcobacter gen. nov. Int J Syst Bacteriol (1991) 6.16
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology (2004) 5.94
Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol (1994) 5.68
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44
Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology (2005) 5.26
Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology (1998) 5.02
Dysbiosis in inflammatory bowel disease. Gut (2004) 5.01
Crohn's disease-isolated mycobacteria are identical to Mycobacterium paratuberculosis, as determined by DNA probes that distinguish between mycobacterial species. J Clin Microbiol (1987) 4.47
Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology (1998) 4.30
Trichuris suis therapy in Crohn's disease. Gut (2005) 4.05
Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun (1998) 3.80
Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease. Dig Dis Sci (1984) 3.76
Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J Clin Microbiol (1995) 3.74
Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol (1990) 3.54
Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis (2003) 3.42
Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut (1993) 3.25
Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun (1997) 3.21
Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J (1979) 2.93
Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun (1999) 2.92
Agent transmissible from Crohn's disease tissue. Lancet (1970) 2.89
Helicobacter pullorum sp. nov.-genotype and phenotype of a new species isolated from poultry and from human patients with gastroenteritis. Microbiology (1994) 2.79
Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr (2000) 2.74
TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology (2003) 2.58
Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology (2009) 2.57
Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol (1987) 2.54
The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev (2006) 2.36
Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun (2001) 2.28
Helicobacter canis sp. nov., a new species from dogs: an integrated study of phenotype and genotype. J Gen Microbiol (1993) 2.26
An in-depth study of Crohn's disease in two French families. Gastroenterology (1993) 2.15
Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol (2008) 2.06
Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology (2009) 2.00
Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut (1998) 1.96
Does the failure to acquire helminthic parasites predispose to Crohn's disease? FASEB J (2000) 1.96
Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol (2002) 1.93
Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand J Gastroenterol (2008) 1.89
Further animal evidence of a transmissible agent in Crohn's disease. Lancet (1973) 1.85
Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect Immun (1997) 1.81
Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis (2009) 1.77
Evidence of persistent measles virus infection in Crohn's disease. J Med Virol (1993) 1.76
Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther (2003) 1.73
The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis (2004) 1.72
Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology (2006) 1.71
Misidentifying helicobacters: the Helicobacter cinaedi example. J Clin Microbiol (2000) 1.70
Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun (2005) 1.67
Role of human microflora in health and disease. Eur J Clin Microbiol Infect Dis (1992) 1.64
Preliminary report on isolation of mycobacteria from patients with Crohn's disease. Dig Dis Sci (1989) 1.60
The IL23 axis plays a key role in the pathogenesis of IBD. Gut (2007) 1.58
Crohn's disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology (2004) 1.55
Inflammatory bowel disease: review from the aspect of genetics. J Gastroenterol (2009) 1.51
Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut (1990) 1.51
Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease? Gut (2005) 1.51
Helicobacter trogontum sp. nov., isolated from the rat intestine. Int J Syst Bacteriol (1996) 1.48
A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut (2006) 1.48
Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol (2008) 1.48
Helicobacter canadensis sp. nov. isolated from humans with diarrhea as an example of an emerging pathogen. J Clin Microbiol (2000) 1.47
Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol (2009) 1.39
Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology (2008) 1.31
Intestinal microflora in human and experimental inflammatory bowel disease. Curr Opin Gastroenterol (2001) 1.30
Novel intestinal Helicobacter species isolated from cotton-top tamarins (Saguinus oedipus) with chronic colitis. J Clin Microbiol (1999) 1.30
Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine. Ann Med (2007) 1.29
Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun (2006) 1.26
Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: is IgA antibody a marker for Crohn's disease? Int Arch Allergy Appl Immunol (1990) 1.26
Short- and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis (2008) 1.24
The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology (2008) 1.23
Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon. Gastroenterology (1994) 1.21
Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut (2006) 1.20
'Flexispira rappini' strains represent at least 10 Helicobacter taxa. Int J Syst Evol Microbiol (2000) 1.19
Foodborne bacterial infection and hospitalization: a registry-based study. Clin Infect Dis (2006) 1.18
Microbial factors in inflammatory bowel disease. Gastroenterol Clin North Am (2002) 1.18
Bacteremia caused by a Helicobacter pullorum-like organism. Clin Infect Dis (2001) 1.17
Role of Candida in antibiotic-associated diarrhea. J Infect Dis (2001) 1.17
Genetic aspects of inflammation and cancer. Biochem J (2008) 1.15
The genetics of inflammatory bowel disease. Am J Gastroenterol (2007) 1.14
Nongastric Helicobacter species detected in the intestinal tract of children. J Clin Microbiol (2006) 1.13
Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology (2006) 1.12
Diet and inflammatory bowel disease: a case-control study. Epidemiology (1992) 1.09
Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol (2009) 1.07
Gastrointestinal norovirus infection associated with exacerbation of inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2009) 1.06
Rapid onset of ulcerative typhlocolitis in B6.129P2-IL10tm1Cgn (IL-10-/-) mice infected with Helicobacter trogontum is associated with decreased colonization by altered Schaedler's flora. Infect Immun (2006) 1.03
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62
The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett (2002) 7.29
Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology (2008) 3.25
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe (2013) 3.21
Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol (2002) 2.35
Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces. Int J Syst Evol Microbiol (2002) 2.14
IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol (2012) 2.03
A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology (2006) 1.98
Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol (2004) 1.96
The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol (2009) 1.87
Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology (2002) 1.85
Sporadic colorectal cancer--role of the commensal microbiota. FEMS Microbiol Lett (2005) 1.82
Cancer and inflammation: promise for biologic therapy. J Immunother (2010) 1.72
Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int J Cancer (2006) 1.64
The inflammatory microenvironment in colorectal neoplasia. PLoS One (2011) 1.62
Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS One (2011) 1.58
Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol (2012) 1.54
Gastric cancer. Br Med Bull (2008) 1.53
Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses. Am J Epidemiol (2010) 1.35
Helicobacter Pylori associated global gastric cancer burden. Front Biosci (Landmark Ed) (2009) 1.33
Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. J Med Microbiol (2008) 1.21
Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect Immun (2009) 1.19
Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals. Gastroenterology (2010) 1.18
Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations. Eur J Cancer Prev (2012) 1.17
Anaerostipes caccae gen. nov., sp. nov., a new saccharolytic, acetate-utilising, butyrate-producing bacterium from human faeces. Syst Appl Microbiol (2002) 1.17
Genetic aspects of inflammation and cancer. Biochem J (2008) 1.15
Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunol Med Microbiol (2010) 1.09
Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PLoS One (2011) 1.08
CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations. Eur J Cancer Prev (2009) 1.07
Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol (2007) 1.06
The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol Biomarkers Prev (2005) 1.06
Toxigenic Helicobacter pylori infection precedes gastric hypochlorhydria in cancer relatives, and H. pylori virulence evolves in these families. Clin Cancer Res (2008) 1.05
The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study. PLoS One (2013) 1.03
Helicobacter pylori infection, host genetics and gastric cancer. J Dig Dis (2009) 1.03
A comprehensive evaluation of colonic mucosal isolates of Sutterella wadsworthensis from inflammatory bowel disease. PLoS One (2011) 0.96
Current status of Barrett's esophagus research in Asia. J Gastroenterol Hepatol (2011) 0.96
Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population. Jpn J Clin Oncol (2008) 0.92
The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers. Histopathology (2009) 0.92
Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy. Clin Gastroenterol Hepatol (2004) 0.90
Helicobacter pylori: host genetics and disease outcomes. Expert Rev Gastroenterol Hepatol (2008) 0.89
Two-stage genome-wide methylation profiling in childhood-onset Crohn's Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci. Inflamm Bowel Dis (2014) 0.89
Oceanicaulis alexandrii gen. nov., sp. nov., a novel stalked bacterium isolated from a culture of the dinoflagellate Alexandrium tamarense (Lebour) Balech. Int J Syst Evol Microbiol (2003) 0.87
The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk. Can J Gastroenterol (2003) 0.87
Biochemical characterization of Sinorhizobium meliloti mutants reveals gene products involved in the biosynthesis of the unusual lipid A very long-chain fatty acid. J Biol Chem (2011) 0.86
The mesenchyme in malignancy: a partner in the initiation, progression and dissemination of cancer. Pharmacol Ther (2012) 0.86
Images of colonic real-time tissue sonoelastography correlate with those of colonoscopy and may predict response to therapy in patients with ulcerative colitis. BMC Gastroenterol (2011) 0.86
Role of host genetics in fibrosis. Fibrogenesis Tissue Repair (2009) 0.86
Genetics of inflammation in the gastrointestinal tract and how it can cause cancer. Recent Results Cancer Res (2011) 0.86
Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: a case-control and immunohistochemical study. BMC Res Notes (2012) 0.83
Possible association between a genetic polymorphism at 8q24 and risk of upper gastrointestinal cancer. Eur J Cancer Prev (2011) 0.82
The gut microbiota, dietary extremes and exercise. Gut (2014) 0.82
Cytokine gene polymorphisms, cytokine levels and the risk of colorectal neoplasia in a screened population of Northeast Scotland. Eur J Cancer Prev (2015) 0.81
Western lifestyle: a 'master' manipulator of the intestinal microbiota? Gut (2013) 0.80
MicroRNAs, a superimposed regulatory network important for development and disease. Int J Biochem Cell Biol (2010) 0.78
Genetic aspects of inflammation. Curr Opin Pharmacol (2009) 0.78
Helicobacter pylori susceptibility in the GWAS era. JAMA (2013) 0.76
The other Helicobacters. Helicobacter (2011) 0.76
MicroRNAs in gastrointestinal malignancy: a tool in cancer prevention? Eur J Cancer Prev (2014) 0.76
Genetics of Barrett's: the bigger, the better. Am J Gastroenterol (2012) 0.75
How accurate are fecal tests for determination of cure after Helicobacter pylori eradication therapy? Nat Clin Pract Gastroenterol Hepatol (2007) 0.75
Programmed chemotherapy for patients with metastatic unresectable gastric cancer. PLoS One (2012) 0.75
Esophageal cancers and Helicobacter pylori: do host genes matter? Gastroenterology (2010) 0.75
Revision of the Atlanta classification of acute pancreatitis: the editorial perspective. Gut (2013) 0.75
Not All Mice Are the Same: Standardization of Animal Research Data Presentation. Cell Mol Gastroenterol Hepatol (2016) 0.75
A multi-journal partnership to highlight joint first-authors of manuscripts. Gastrointest Endosc (2015) 0.75
GP management of dyspepsia. Practitioner (2006) 0.75
A multi-journal partnership to highlight joint first-authors of manuscripts. Hepatology (2015) 0.75
A multi-journal partnership to highlight joint first-authors of manuscripts. Gastroenterology (2015) 0.75